TI
BCYC

Trexquant Investment’s Bicycle Therapeutics BCYC Stock Holding History

Trexquant Investment’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-92,552
Closed -$2.3M – 1521
2024
Q1 		$2.3M Sell
92,552
-103,771
-53% -$2.2M 0.05% 592
2023
Q4 		$3.55M Buy
196,323
+125,604
+178% +$2.08M 0.08% 358
2023
Q3 		$1.42M Buy
+70,719
New +$1.62M 0.04% 611
2022
Q3 		– Sell
-10,899
Closed -$183K – 1363
2022
Q2 		$183K Buy
+10,899
New +$230K 0.01% 1373
2022
Q1 		– Sell
-4,370
Closed -$266K – 1359
2021
Q4 		$266K Buy
+4,370
New +$241K 0.02% 992

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Trexquant Investment's BCYC Position: Q2 2024 in Review

Trexquant Investment sold out of Bicycle Therapeutics (BCYC) in Q2 2024, closing a stake of 92,552 shares — an estimated $2.3M sold.

Trexquant Investment first reported a position in BCYC in Q4 2021 and held it in 5 quarters. The position peaked at $3.55M in Q4 2023. 107 funds tracked by Wall St. Rank hold BCYC as of Q2 2024.

  • Trexquant Investment reported no remaining Bicycle Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Trexquant Investment sold 92,552 Bicycle Therapeutics shares in Q2 2024, an estimated $2.3M.
  • Trexquant Investment first reported a position in Bicycle Therapeutics in Q4 2021 and held it in 5 quarters.
  • Trexquant Investment's Bicycle Therapeutics position peaked at $3.55M in Q4 2023.
  • 107 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2024.

Based on Trexquant Investment's 13F filing for Q2 2024, filed 13 Aug 2024.